Boston, May 5, 2026 — Velsera, a leading global healthcare technology company advancing precision medicine, today announced the appointment of Kareem Saad as President and Chief Business Officer. In this role, Saad will lead all commercial and business functions globally across the organization, helping drive Velsera’s transition from stabilization to sustained growth as the adoption of precision medicine continues to accelerate in the U.S. and globally.
Mr. Saad brings extensive leadership experience building and scaling commercial organizations, alongside deep expertise overseeing strategic finance functions across both large enterprises and high-growth companies in the precision medicine and broader healthcare ecosystem. His track record includes driving revenue expansion, optimizing go-to-market strategies, and aligning financial and operational performance to support long-term value creation. Mr. Saad has also successfully led $4B+ in strategic transactions in the precision medicine space across the spectrum of corporate development and strategic financings.
At Velsera, Mr. Saad will be responsible for bolstering the company’s financial foundation, advancing its commercial strategy, strengthening customer engagement, and unlocking new growth opportunities across its portfolio of data-driven solutions that enable personalized healthcare.
“I’m incredibly excited to join Velsera at such a pivotal moment,” said Kareem Saad. “The company has built a strong foundation, and I’m energized by the opportunity to work with the strong team in place to accelerate its next phase of growth. As precision medicine continues to gain momentum across the healthcare landscape, I’m very bullish on Velsera’s ability to play a central role in shaping that future—both in the U.S. and globally.”
Jamie Coffin, Chief Executive Officer of Velsera, added, “We are thrilled to welcome Kareem to Velsera. He is a proven leader with a unique combination of commercial acumen and financial discipline, and his experience across organizations of varying scale will be invaluable as we continue to grow. On a personal note, I’m especially excited to be joining forces with Kareem again—his leadership, energy, and strategic mindset make him the ideal partner for this next chapter.”
Mr. Saad’s appointment underscores Velsera’s commitment to strengthening its leadership team as it builds on recent progress and positions itself to capitalize on the expanding role of precision medicine in transforming healthcare delivery.
About Velsera
Velsera is a global healthcare technology company dedicated to advancing precision medicine by connecting complex data with innovative analytics and clinical insights. The company partners with biopharma, diagnostics, and healthcare organizations to improve patient outcomes and accelerate the development and delivery of personalized therapies.
Media Contact:
Pavel Gongora
Pavel.Gongora@velsera.com